Benzinga | Aug 12, 2020 07:33AM EDT

Truist Securities Maintains Buy on Integra Lifesciences, Raises Price Target to $60

Truist Securities maintains Integra Lifesciences (NASDAQ:IART) with a Buy and raises the price target from $55 to $60.